How to Deliver a Biotech Facility 3 Years Faster Than Traditional Build Construction Methods

Georgi Makin
5 May 2023
Cell Therapy
Finance & Investment
Gene Therapy
Scaling Up
This Briefing from Advanced Therapies Week 2023 focusses on the delivery of a fully funded, third party biotech facility over an expedited timeline compared to traditional build construction methods.

During this session, Tony Wells (CEO) and Matthew Toomey (Business Development Director) from Merit are joined by Piers Slater, CEO at Reef Group, Will Rohleder, Director at Reef Group, Miranda Neville, VP of Global Operations & Delivery at Autolus and Olivia Drew, Portfolio Manager at UBS UK Life Sciences.

This Briefing was presented at Advanced Therapies Week 2023, in partnership with Merit.